Silence Therapeutics (SLN) Tax Rate (2024 - 2025)

Silence Therapeutics (SLN) reported Tax Rate of 0.0% for Q3 2025, up 13.0% on a YoY basis from 0.0% in Q3 2024, and up 86.95% sequentially from 0.04% in Q2 2025.

Silence Therapeutics (SLN) Tax Rate (2024 - 2025) Analysis & Trends

Silence Therapeutics (SLN) has 2 years of Tax Rate data on file, last reported at 0.0% in Q3 2025.

  • For the quarter ending Q3 2025, Tax Rate rose 13.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (down 1603.0% YoY), and the FY2025 full-year result was 0.01%, down 2501.0% from the prior year.
  • Tax Rate climbed to 0.0% in Q3 2025, from 0.04% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.0% in Q3 2025 to a low of 92.17% in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -0.34
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 5.61
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 12.29
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 17.68
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 12.51
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -13.70
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Silence Therapeutics 1.59 Bn 1.45 Bn 411,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Sep 30, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 -0.04
Jun 30, 2025 -0.04
Jun 30, 2025 -0.04
Dec 31, 2024 -92.17
Dec 31, 2024 -92.17
Dec 31, 2024 -92.17
Sep 30, 2024 -0.14
Sep 30, 2024 -0.14
Sep 30, 2024 -0.14
Jun 30, 2024 -1.17
Jun 30, 2024 -1.17
Jun 30, 2024 -1.17
Mar 31, 2024 -11.80
Mar 31, 2024 -11.80
Mar 31, 2024 -11.80